Suchergebnisse - "Norton, Elizabeth B."

PubPharm (10)

1

Recent advances in enterotoxin vaccine adjuvants

enthalten in: Current opinion in immunology | 2023

von Crothers, J. | Norton, E.

2

Identifying a stable bulk dmLT adjuvant formulation at a clinically relevant concentration

enthalten in: Vaccine | 2023

von Estrada, M. | Bzami, A. | Norton, E. | +1

3

Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+ T cell responses and impair oral vaccine efficacy

enthalten in: Immunity | 2021

von Bhattacharjee, A. | Burr, A. | Overacre-Delgoffe, A. | +11

4

Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli

enthalten in: Infection and immunity | 2019

von Maciel, M. | Bauer, D. | Baudier, R. | +7

5

The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT

enthalten in: mSphere | 2018

von Clements, J. | Norton, E.

6

Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)

enthalten in: PloS one | 2015

von Norton, E. | Branco, L. | Clements, J.

ErratumIn: PLoS One. 2015;10(9):e0138938. - PMID 26383114

7

Simultaneous exposure to Escherichia coli heat-labile and heat-stable enterotoxins increases fluid secretion and alters cyclic nucleotide and cytokine production by intestinal epithelial cells

enthalten in: Infection and immunity | 2014

von Read, L. | Hahn, R. | Thompson, C. | +3

8

The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens

enthalten in: Infection and immunity | 2012

von Norton, E. | Lawson, L. | Mahdi, Z. | +2

9

Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant

enthalten in: Clinical and vaccine immunology : CVI | 2011

von Norton, E. | Lawson, L. | Freytag, L. | +1

10

Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model

enthalten in: Journal of virology | 2010

von Norton, E. | Clements, J. | Voss, T. | +1

1
[1]